(Est time: 0.5 hrs) This module provides an overview of the patient-centered approach to treating opioid use disorder with buprenorphine, the laws for prescribing buprenorphine, and the training requirement.

Goal: To introduce providers to office-based opioid treatment with buprenorphine, including its importance, effectiveness, approach, and training requirement.

Module Objectives:

Recognize the need for opioid use disorder treatment given its prevalence

Apply a patient-centered approach in a buprenorphine practice

Describe buprenorphine's status as a controlled substance and the laws governing the prescribing of this medication

Describe the requirements to receive a waiver to prescribe buprenorphine

Explain the process of becoming certified to prescribe buprenorphine for patients with opioid use disorder

(Est time: 1 hr) This module describes how to screen for opioid use disorder and other substance use disorders and utilize communication skills for interacting with patients in a buprenorphine practice.

Goal: To prepare providers to screen for and diagnose opioid use disorder and motivate patients to change.

Module Objectives:

Use motivational interviewing skills to optimize patient communication in a buprenorphine practice

Screen for opioid use disorder through patient interviews and use of standardized screening instruments

(Est time: 1 hr) This module describes adaptations that are needed in a buprenorphine practice to meet the needs of patient subpopulations, including patients transferring from methadone to buprenorphine.

Goal: To prepare providers to adapt a buprenorphine practice to the needs of patient subpopulations, including patients transferring from methadone to buprenorphine.

Module Objectives:

Modify buprenorphine treatment as needed for patients who are transferring from methadone treatment to buprenorphine

Recognize, anticipate, and address complications of buprenorphine treatment in patients using multiple other substances

Funding Information

Development of this website was funded entirely by grant #R44DA12066 and contract #HHSN271200655304C from the National Institute on Drug Abuse (NIDA) at the National Institutes of Health. The website contents are solely the responsibility of the authors and do not necessarily represent the official views of NIDA. Ongoing development and maintenance is funded by the training fee and Clinical Tools, Inc. No commercial support is received.

Clinical Tools, Inc. is accredited by the ACCME to provide continuing medical education for physicians.